StonvexLoading…
StonvexStonvexStonvexCore line items from RNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $644.20M | $2.52B | $1.87B | $1.23B |
Operating Income | $50.03M | $120.55M | $78.11M | $47.30M |
Net Income | $30.62M | $43.39M | $20.42M | $13.19M |
EPS (Diluted) | $0.35 | $0.48 | $0.22 | $0.03 |
Total Assets | $1.42B | $1.48B | $1.53B | $1.61B |
Total Liabilities | $1.83B | $1.87B | $1.86B | $1.89B |
Cash & Equivalents | $116.58M | $132.56M | $145.37M | $168.11M |
Free Cash Flow OCF − CapEx | $157.50M | $587.32M | $446.32M | $302.53M |
Shares Outstanding | 86.99M | 91.21M | 92.31M | 92.49M |